BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 32416270)

  • 1. Updating Photon-Based Normal Tissue Complication Probability Models for Pneumonitis in Patients With Lung Cancer Treated With Proton Beam Therapy.
    Jain V; Niezink AGH; Frick M; Doucette A; Mendes A; Simone CB; Langendijk JA; Wijsman R; Feigenberg SJ; Levin W; Cengel KA; van der Schaaf A; Berman AT
    Pract Radiat Oncol; 2020; 10(5):e330-e338. PubMed ID: 32416270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. External validation of NTCP-models for radiation pneumonitis in lung cancer patients treated with chemoradiotherapy.
    Niezink AGH; van der Schaaf A; Wijsman R; Chouvalova O; van der Wekken AJ; Rutgers SR; Pieterman RM; van Putten JWG; de Hosson SM; van der Leest AHD; Ubbels JF; Woltman-van Iersel M; Widder J; Langendijk JA; Muijs CT
    Radiother Oncol; 2023 Sep; 186():109735. PubMed ID: 37327975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of radiation pneumonitis using the effective α/β of lungs and heart in NSCLC patients treated with proton beam therapy.
    Weiß A; Löck S; Xu T; Liao Z; Hoffmann AL; Troost EGC
    Radiother Oncol; 2024 Jan; 190():110013. PubMed ID: 37972734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose to Highly Functional Ventilation Zones Improves Prediction of Radiation Pneumonitis for Proton and Photon Lung Cancer Radiation Therapy.
    O'Reilly S; Jain V; Huang Q; Cheng C; Teo BK; Yin L; Zhang M; Diffenderfer E; Li T; Levin W; Xiao Y; Dong L; Feigenberg S; Berman AT; Zou W
    Int J Radiat Oncol Biol Phys; 2020 May; 107(1):79-87. PubMed ID: 31987966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spatial Dose Patterns Associated With Radiation Pneumonitis in a Randomized Trial Comparing Intensity-Modulated Photon Therapy With Passive Scattering Proton Therapy for Locally Advanced Non-Small Cell Lung Cancer.
    Palma G; Monti S; Xu T; Scifoni E; Yang P; Hahn SM; Durante M; Mohan R; Liao Z; Cella L
    Int J Radiat Oncol Biol Phys; 2019 Aug; 104(5):1124-1132. PubMed ID: 30822531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toward a model-based patient selection strategy for proton therapy: External validation of photon-derived normal tissue complication probability models in a head and neck proton therapy cohort.
    Blanchard P; Wong AJ; Gunn GB; Garden AS; Mohamed ASR; Rosenthal DI; Crutison J; Wu R; Zhang X; Zhu XR; Mohan R; Amin MV; Fuller CD; Frank SJ
    Radiother Oncol; 2016 Dec; 121(3):381-386. PubMed ID: 27641784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors predicting radiation pneumonitis in lung cancer patients: a retrospective study.
    Rancati T; Ceresoli GL; Gagliardi G; Schipani S; Cattaneo GM
    Radiother Oncol; 2003 Jun; 67(3):275-83. PubMed ID: 12865175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proton Therapy in Non-small Cell Lung Cancer.
    Mesko S; Gomez D
    Curr Treat Options Oncol; 2018 Nov; 19(12):76. PubMed ID: 30483900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First Clinical Report of Proton Beam Therapy for Postoperative Radiotherapy for Non-Small-Cell Lung Cancer.
    Remick JS; Schonewolf C; Gabriel P; Doucette A; Levin WP; Kucharczuk JC; Singhal S; Pechet TTV; Rengan R; Simone CB; Berman AT
    Clin Lung Cancer; 2017 Jul; 18(4):364-371. PubMed ID: 28162946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical results of proton beam therapy in patients with idiopathic pulmonary fibrosis: a single center experience.
    Ono T; Hareyama M; Nakamura T; Kimura K; Hayashi Y; Azami Y; Hirose K; Hatayama Y; Suzuki M; Wada H; Kikuchi Y; Nemoto K
    Radiat Oncol; 2016 Apr; 11():56. PubMed ID: 27090216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perspectives on the model-based approach to proton therapy trials: A retrospective study of a lung cancer randomized trial.
    McNamara AL; Hall DC; Shusharina N; Liu A; Wei X; Ajdari A; Mohan R; Liao Z; Paganetti H
    Radiother Oncol; 2020 Jun; 147():8-14. PubMed ID: 32224318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective study of the feasibility of FDG-PET/CT imaging to quantify radiation-induced lung inflammation in locally advanced non-small cell lung cancer patients receiving proton or photon radiotherapy.
    Jahangiri P; Pournazari K; Torigian DA; Werner TJ; Swisher-McClure S; Simone CB; Alavi A
    Eur J Nucl Med Mol Imaging; 2019 Jan; 46(1):206-216. PubMed ID: 30229527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of Effective Dose as a Better Predictor of Radiation Pneumonitis Risk Than Mean Lung Dose: Secondary Analysis of a Randomized Trial.
    Tucker SL; Xu T; Paganetti H; Deist T; Verma V; Choi N; Mohan R; Liao Z
    Int J Radiat Oncol Biol Phys; 2019 Feb; 103(2):403-410. PubMed ID: 30291994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in lung injury after IMRT or proton therapy assessed by
    Shusharina N; Liao Z; Mohan R; Liu A; Niemierko A; Choi N; Bortfeld T
    Radiother Oncol; 2018 Jul; 128(1):147-153. PubMed ID: 29352608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of toxicity grade and scoring system on the relationship between mean lung dose and risk of radiation pneumonitis in a large cohort of patients with non-small cell lung cancer.
    Tucker SL; Jin H; Wei X; Wang S; Martel MK; Komaki R; Liu HH; Mohan R; Chen Y; Cox JD; Liao Z
    Int J Radiat Oncol Biol Phys; 2010 Jul; 77(3):691-8. PubMed ID: 19836159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Outcomes and Prognostic Factors of High-Dose Proton Beam Therapy for Peripheral Stage I Non-Small-Cell Lung Cancer.
    Hatayama Y; Nakamura T; Suzuki M; Azami Y; Ono T; Yabuuchi T; Hayashi Y; Kimura K; Hirose K; Wada H; Hareyama M; Kikuchi Y; Takai Y
    Clin Lung Cancer; 2016 Sep; 17(5):427-432. PubMed ID: 26725851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Normal Tissue Complication Probability Modelling for Toxicity Prediction and Patient Selection in Proton Beam Therapy to the Central Nervous System: A Literature Review.
    Gaito S; Burnet N; Aznar M; Crellin A; Indelicato DJ; Ingram S; Pan S; Price G; Hwang E; France A; Smith E; Whitfield G
    Clin Oncol (R Coll Radiol); 2022 Jun; 34(6):e225-e237. PubMed ID: 35042622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypofractionated Proton Beam Therapy for cT1-2N0M0 Non-small Cell Lung Cancer Patients With Interstitial Lung Disease.
    Saito T; Ohnishi K; Ishikawa H; Nakamura M; Hoshiai S; Numajiri H; Murofushi KN; Mizumoto M; Okumura T; Sakurai H
    Anticancer Res; 2021 Nov; 41(11):5635-5642. PubMed ID: 34732436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluating Which Dose-Function Metrics Are Most Critical for Functional-Guided Radiation Therapy.
    Faught AM; Yamamoto T; Castillo R; Castillo E; Zhang J; Miften M; Vinogradskiy Y
    Int J Radiat Oncol Biol Phys; 2017 Sep; 99(1):202-209. PubMed ID: 28816147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Proton beam therapy with concurrent chemotherapy for non-small cell lung cancer -- our experiences and future direction].
    Niho S; Motegi A; Akimoto T
    Gan To Kagaku Ryoho; 2015 Feb; 42(2):144-7. PubMed ID: 25743132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.